Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Divi’s Laboratories has informed that it enclosed the schedule of earnings conference call for Q3FY23 to be held on February 03, 2023.
The above information is a part of company’s filings submitted to BSE.